Human Embryonic Stem Cells: Disease Treatment and Ethics
This paper examines the therapeutic potential of human embryonic stem cells (hESCs) across multiple disease categories, including cardiac conditions, neurological disorders, and liver failure. Beginning with an overview of hESC derivation from the inner cell mass of human blastocysts, the paper discusses protocols for generating cardiomyocytes, neurons, and hepatocytes from these cells. It reviews applications for specific conditions such as Parkinson's disease, stroke, Huntington's disease, amyotrophic lateral sclerosis, and ischemic heart disease. The paper also addresses the significant ethical controversies surrounding hESC research, including questions about the moral value of the embryo, the destruction of human life at its earliest stage, and concerns about the social exploitation of women who donate ova and embryos for research purposes.
- Introduction to Embryonic Stem Cells: Properties, origins, and therapeutic potential of hESCs
- Derivation and Cardiac Applications of Human Embryonic Stem Cells: Deriving hESCs and generating cardiomyocytes for heart disease
- Neurological Disorders and Stem Cell Therapy: hESC applications for Parkinson's, stroke, ALS, and Huntington's
- Hepatic Cell Generation from Human Embryonic Stem Cells: Using hESCs to generate functional liver cells
- Ethical Considerations of Using Human Embryonic Stem Cells: Moral debates over embryo destruction and social exploitation
- Conclusion: Summary of therapeutic promise and unresolved ethical tensions
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper systematically moves from basic science (derivation and properties of hESCs) to specific clinical applications and then to ethical debate, creating a logical and readable progression.
- Each disease application is handled in its own subsection, making it easy to locate specific clinical uses and assess the current state of research for each condition.
- The ethical section balances multiple perspectives — theological, feminist, and bioethical — rather than presenting a single viewpoint, demonstrating intellectual fairness.
Key academic technique demonstrated
The paper effectively integrates scientific literature with ethical analysis. By grounding each therapeutic claim in specific peer-reviewed citations before transitioning to the broader moral debate, the author demonstrates how empirical evidence and normative argument can coexist within a single research paper without conflating the two registers.
Structure breakdown
The paper opens with background on stem cell biology and hESC derivation, then moves through cardiac, neurological, and hepatic applications in turn. Each clinical section follows a consistent pattern: describing the disease, surveying current therapies, and explaining how hESCs offer improvements. The final two sections shift to ethical analysis, covering the conflict between alleviating human suffering and protecting embryonic life, social concerns about exploitation, and philosophical views on the moral status of the embryo. A brief conclusion synthesizes both the therapeutic promise and the ethical tensions.
Introduction to Embryonic Stem Cells
Pluripotent stem cell cultures were first isolated in 1981 by Evans and Kaufman from mouse blastocysts. It was found that these cells were capable of self-renewal, with a long-term capacity to remain undifferentiated under certain culture conditions. Studies have highlighted the basic difference between stem cells and embryonic stem cells. Embryonic stem cells have the potential to differentiate into all three germ layers. These cells also have the capacity to proliferate in culture conditions in an undifferentiated state, and they typically disappear after differentiating into germ layers. For clinical purposes, the origin of human embryonic stem cells is the pre-implantation embryo. Stem cell lines have been derived from the inner cell mass of human blastocysts produced by in vitro fertilization. Studies have shown that human embryonic stem cells share the key properties of embryonic stem cells (Cai et al. 2007, p. 1229). These properties include derivation from the pre-implantation embryo, prolonged proliferation in culture in an undifferentiated state, and the capacity to form all three germ layers. In addition, human embryonic stem cells can maintain a diploid karyotype and exhibit higher telomerase activity when kept in culture for extended periods.
There are two main properties of embryonic stem cells: indefinite cell renewal and the ability to differentiate into one or more cell types. Successful studies and applications of murine embryonic stem cell research have paved the way for exploring the important applications of human embryonic stem cells. Several tissues in the human body depend on a pool of adult or somatic stem cells for maintenance. These tissues include the hematopoietic system, skin, gut, and parts of the central nervous system. Studies have shown that depletion of stem cell pools can lead to many diseases, including leukemia, lymphoma, and certain genetic defects. Other diseases involve tissue destruction in which the affected tissues cannot be revived by stem cell pools. These conditions include Type 1 diabetes, which arises from autoimmune destruction of pancreatic beta cells, and liver failure resulting from cirrhosis caused by toxins or infectious agents (Zou et al. 2009, p. 98). The main approach to treating these diseases is replacement of the stem cell pools in the body. Reports have highlighted the success of bone marrow transplants and direct organ transplants. Human embryonic stem cells can be triggered to differentiate into adult stem cells to replace the damaged stem cell pool, thereby regenerating damaged or diseased tissues and organs clinically (Lerou and Daley, 2005, p. 321). Organ transplantation has been less favored than stem cell replenishment because of immune barriers, where immunosuppression becomes necessary to prevent graft rejection (Gepstein, 2002, p. 869).
For proper clinical and medical usage of embryonic stem cells, it is important that the developmental pathways of tissues within an embryo are studied and understood. Many kinds of embryonic stem cells have been characterized, including insulin-secreting cells, neural tissue, cardiomyocytes, endothelial cells, hematopoietic cells, hepatocytes, and osteoblasts. Stem cells can therefore be used clinically to treat medical conditions affecting these tissues and cell types (Lindvall and Kokaia, 2006, p. 1095).
References
Barberi, T., Willis, M.L., Socci, D.N., and Studer, L. (2006). Derivation of Multipotent Mesenchymal Precursors from Human Embryonic Stem Cells. PLoS Medicine 2(6): p. 0554–0560.
Bhattacharya, B., Miura, T., Brandenberger, R., Mejido, J., Luo, Y., Yang, X.A., Joshi, H.B., Ginis, I., Thies, S.R., Amit, M., Lyons, I., Condie, G.B., Itskovitz-Eldor, J., Rao, S.M., and Puri, K.R. (2004). Gene expression in human embryonic stem cell lines: unique molecular signature. Blood 103: 2956–2964.
Cai, J., Zhao, Y., Liu, Y., Ye, F., Song, Z., Qin, H., Meng, S., Chen, Y., Zhou, R., Song, X., Guo, Y., Ding, M., and Deng, H. (2007). Directed Differentiation of Human Embryonic Stem Cells into Functional Hepatic Cells. Hepatology 45: 1229–1239.
Gepstein, L. (2002). Derivation and Potential Applications of Human Embryonic Stem Cells. Circulation Research 91: 866–876.
Kehat, I., Kenyagin-Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz-Eldor, J., and Gepstein, L. (2001). Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. Journal of Clinical Investigation 108: 407–414.
Lerou, H.P., and Daley, Q.G. (2005). Therapeutic potential of embryonic stem cells. Blood Reviews 19: 321–331.
Lindvall, O., and Kokaia, Z. (2006). Stem cells for the treatment of neurological disorders. Nature 441: 1094–1096.
Mummery, C., Oostwaard, W.D., Doevendans, P., Spijker, R., van den Brink, S., Hassink, R., van der Heyden, M., Opthof, M., Pera, M., de la Riviere, B.A., Passier, R., and Tertoolen, L. (2002). Differentiation of Human Embryonic Stem Cells to Cardiomyocytes: Role of Coculture With Visceral Endoderm-Like Cells. Circulation 107: 2733–2740.
Stojkovic, M., Lako, M., Strachan, T., and Murdoch, A. (2004). Derivation, growth and applications of human embryonic stem cells. Reproduction 128: 259–267.
Zou, J., Maeder, L.M., Mali, P., Pruett-Miller, M.S., Thibodeau-Beganny, S., Chou, B., Chen, G., Ye, Z., Park, I., Daley, Q.G., Porteus, H.M., Joung, K., and Cheng, L. (2009). Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 5(1): 97–110.
Create your account
Always verify citation format against your institution’s current style guide requirements.